CollPlant Biotechnologies (CLGN) Cash from Discontinued Operations (2020 - 2021)
CollPlant Biotechnologies (CLGN) reported Cash from Discontinued Operations of 2817000.0 for Q3 2021, down 289.19% on a YoY basis from 1489000.0 in Q3 2020, and up 13.59% quarter-over-quarter from 3260000.0 in Q2 2021.
CollPlant Biotechnologies (CLGN) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends
CollPlant Biotechnologies has reported Cash from Discontinued Operations for 2 years, with the latest figure at 2817000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discont. Ops (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -59.14 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -2.82 Mn |
| Sep 30, 2021 | -2.82 Mn |
| Jun 30, 2021 | -3.26 Mn |
| Jun 30, 2021 | -3.26 Mn |
| Mar 31, 2021 | 11.00 Mn |
| Mar 31, 2021 | 11.00 Mn |
| Sep 30, 2020 | 1.49 Mn |
| Sep 30, 2020 | 1.49 Mn |
| Jun 30, 2020 | -6.93 Mn |
| Jun 30, 2020 | -6.93 Mn |
| Mar 31, 2020 | 2.59 Mn |
| Mar 31, 2020 | 2.59 Mn |